Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Biotech company Forty Seven surges 30% after hours on report of Gilead interest [MarketWatch]

FORTY SEVEN (FTSV) 
Last forty seven earnings: 11/12 07:01 am Check Earnings Report
Company Research Source: MarketWatch
Biotech company Forty Seven surges 30% after hours on report of Gilead interest Shares of cancer-therapy company Forty Seven Inc. FTSV, +1.01% shot up more than 30% in after-hours trading Thursday after a report that Gilead Sciences Inc. GILD, -2.73% has made a takeover offer. Bloomberg News reported that Gilead and Forty Seven, a biotech firm that specializes in cancer immunotherapy, are discussing a number of options, including a partnership, and the company was said to have other suitors as well. Forty Seven's stock is up 192% over the past year, with a market cap of around $2.3 billion. Gilead shares ticked up slightly in extended trading. Show less Read more
Impact Snapshot
Event Time:
FTSV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for FTSV alerts
Opt-in for
FTSV alerts

from News Quantified
Opt-in for
FTSV alerts

from News Quantified